Moreover, FGFR2 mutations have previously been linked to bone development and growth diseases, such as Apert syndrome [86], a genetic syndrome characterized by untimely early fusion of the skull bones during development that displays skeletal class III malocclusion [87,88]. Here, FGFR2 is linked to Apert syndrome.